Efficacy and tolerability of natural synergised pyrethrins in a new thermo labile foam formulation in topical treatment of scabies: A prospective, randomised, investigator-blinded, comparative trial vs. permethrin cream

European Journal of Dermatology

Volumn 13, Issue 1, 2003, Pages 69-71

  Amerio, PierLuigi ^a   Capizzi, Rodolfo ^a   Milani, Massimo ^a,b  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b R and D Mipharm   (Italy)

Author keywords

Permethrin; Pyrethrins; Randomised controlled trial; Scabies; Thermolabile foam

Indexed keywords

MILICE; PERMETHRIN; PYRETHROID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENTIATION; DRUG TOLERABILITY; FEMALE; FOAM; HUMAN; MALE; PROSPECTIVE STUDY; PRURITUS; QUANTITATIVE ANALYSIS; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SCABIES; SCORING SYSTEM; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADULT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INSECTICIDES; MALE; PERMETHRIN; PESTICIDE SYNERGISTS; PIPERONYL BUTOXIDE; PROSPECTIVE STUDIES; SCABIES;

EID: 0037286549     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Estes S.A. Diagnosis and management of scabies. Med Clin North Am 1982; 66: 955-63.
2. Fain A. Epidemiological problems of scabies. Int J Dermatol 1978; 17: 20-30.
3. Chosidow O. Scabies and pediculosis. Lancet 2000; 355: 819-26.
4. Bigby M. A systematic review of the treatment of scabies. Arch Dermatol 2000; 136: 387-9.
5. Walker GJA, Johnstone PW. Intervention for treating scabies. The Cochrane Library 2001; Issue 4.
6. Burgess IF, Brown C, Burgess NA. Synergized pyrethrin mousse, a new approach to head lice eradication: efficacy in field and laboratory studies. Clin Ther 1994; 16: 57-64.
7. Franz TJ, Parsell DA, Halualani RM, Hannigan JF, Kalbach JP, Harkonen WS. Betamethasone valerate foam 0, 12%: a novel vehicle with enhanced delivery and efficacy. Int J Dermatol 1999; 38: 628-32.
8. Amer M, El-Gharib I. Permethrin versus crotamiton and lindane in the treatment af scabies. Int J Dermatol 1992; 31: 357-8.
9. Taplin D, Meinking TL, Chen JA, Sanchez R. Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children. Pediatr Dermatol 1990; 7: 67-73.
10. Shulz MW, Gomez M, Hansen RC, Mills J, Menter A, Rodgers H, Judson FN, Mertz G, Handsfield HH. Comparative study of 5% permethrine cream and 1% lindane lotion for the treatment of scabies. Arch Dermatol 1990; 126: 167-70.
11. Hansen RC, Remmers E, Menter MA. A controlled comporotive trial of permethrin 5 per cent cream ond 1 per cent lindane lotion for the treatment of scabies. Clin Res 1986; 34: 160.
12. Green M. Epidemiology of scabies. Epidemiol Rev 1989; 11: 126-50.
13. Andreassi L, Giannetti A, Milani M. Efficacy of betomethasone valerate mousse in comparison with standard therapies on scalp psoriasis: an open, multi-centre, randomised, controlled, cross-over study on 241 patients. Br J Dermatol; in press.